Nystatin Swish and Swallow for Oral Thrush
For mild oral thrush, use nystatin suspension 4-6 mL (400,000-600,000 units) four times daily for 7-14 days, instructing patients to swish thoroughly before swallowing; however, for moderate to severe disease, oral fluconazole 100-200 mg daily is superior and should be used instead. 1
Dosing Protocol
Standard Adult and Pediatric Dosing
- Nystatin suspension (100,000 units/mL): 4-6 mL four times daily for 7-14 days 1, 2
- Alternative formulation: 1-2 nystatin pastilles (200,000 units each) four times daily for 7-14 days 1
- For infants: 2 mL (200,000 units) four times daily, using a dropper to place half the dose in each side of the mouth 2
- For premature and low birth weight infants: 1 mL four times daily is effective 2
Administration Technique
- Swish the suspension thoroughly in the mouth for at least 2 minutes, ensuring contact with all affected areas 3
- Swallow the medication after swishing rather than spitting it out to treat potential esophageal involvement 3
- Avoid feeding for 5-10 minutes after administration in infants and young children 2
- Continue treatment for at least 48 hours after symptoms disappear and cultures confirm eradication 2
Treatment Algorithm by Disease Severity
Mild Disease (First-Line Options)
- Clotrimazole troches 10 mg five times daily for 7-14 days (preferred over nystatin) 1
- Miconazole mucoadhesive buccal 50-mg tablet applied once daily for 7-14 days 1
- Nystatin suspension or pastilles as detailed above (alternative option) 1
Moderate to Severe Disease
- Oral fluconazole 100-200 mg daily for 7-14 days is the recommended treatment 1
- This represents a strong recommendation with high-quality evidence and should be prioritized over topical agents 1
Fluconazole-Refractory Disease
- Itraconazole solution 200 mg once daily for up to 28 days 1
- Posaconazole suspension 400 mg twice daily for 3 days, then 400 mg daily for up to 28 days 1
- Voriconazole 200 mg twice daily 1
- Intravenous echinocandin or amphotericin B deoxycholate for severe refractory cases 1
Special Populations and Considerations
Denture-Related Candidiasis
- Denture disinfection must accompany antifungal therapy for successful treatment 1, 3
- Use standard nystatin or fluconazole dosing as above 1
HIV-Infected Patients
- Antiretroviral therapy is strongly recommended to reduce recurrent infections 1, 3
- For chronic suppression if needed: fluconazole 100 mg three times weekly 1, 3
- Chronic suppressive therapy is usually unnecessary but may be required for recurrent infections 1
Immunocompromised Patients
- Systemic therapy with fluconazole may be more appropriate than topical nystatin for recurrent infections 3
- Consider higher intensity or longer duration therapy based on immune status 1
Evidence Quality and Clinical Pearls
Nystatin has moderate-quality evidence supporting its use for mild oral thrush 1, while fluconazole has high-quality evidence for moderate to severe disease 1. Research demonstrates that fluconazole achieves 100% clinical cure rates compared to only 32% with nystatin in some pediatric studies 4, though a 2022 meta-analysis showed nystatin remains effective when used appropriately 5.
Common Pitfalls to Avoid
- Do not use nystatin for moderate to severe disease when fluconazole is available and appropriate 1
- Do not discontinue treatment early even if symptoms improve; complete the full 7-14 day course 2
- Do not neglect denture disinfection in denture wearers, as this leads to treatment failure 1
- Do not use nystatin for esophageal candidiasis; systemic therapy is always required 1